| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/24/2008 | CN101327209A Dihydromyricetin injection, powder injection and preparation method thereof |
| 12/24/2008 | CN101327204A Use of emodic acid in preventing and treating fatty liver |
| 12/24/2008 | CN101327203A Gallic acid chelates composition and uses thereof |
| 12/24/2008 | CN101327200A Glycerol fruit sugar injection and preparation method thereof |
| 12/24/2008 | CN101327198A Thiazolidinedione metallic salt medicament enteric-coated formulation and preparation method thereof |
| 12/24/2008 | CN101327032A Health tea for treating diabetes |
| 12/24/2008 | CN101327014A Food specially formulated for diabetes and preparation method thereof |
| 12/24/2008 | CN101327013A Rice flour for nourishing stomach and protecting intestines and formulating method thereof |
| 12/24/2008 | CN101327004A Health food for regulating blood fat and improving gastrointestinal tract function and preparation method thereof |
| 12/24/2008 | CN101327003A Method for preparing garlic product |
| 12/24/2008 | CN101326954A Method for producing feed containing Ganoderma lucidum acid from wheat straw transformed by Ganoderma lucidum |
| 12/24/2008 | CN100445300C GLP-1 fusion protein and its preparation method and medicinal uses |
| 12/24/2008 | CN100445297C Amolops loloensis insulin release promoting peptide and use in producing medicine |
| 12/24/2008 | CN100445266C MCH antagonists and their use in treatment of obesity |
| 12/24/2008 | CN100444872C Chinese onion bulb soft capsule and its prepn process and use |
| 12/24/2008 | CN100444864C Chinese medicinal formulation for rehabilitating pancreatic islet function and decreasing blood sugar and preparation process thereof |
| 12/24/2008 | CN100444860C Compound Chinese medicinal extract mixture and its prepration method |
| 12/24/2008 | CN100444858C Fatty acid synthetase inhibitor and preparation method and uses thereof |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CN100444833C Oral dosage form for controlled drug release |
| 12/24/2008 | CA2789109A1 Synthetic bile acid composition, method, and preparation |
| 12/24/2008 | CA2696615A1 Oligosaccharide chain added glp-1 peptide |
| 12/24/2008 | CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | CA2692099A1 Sirtuin modulating imidazothiazole compounds |
| 12/24/2008 | CA2691733A1 Sirtuin modulating compounds |
| 12/24/2008 | CA2691309A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases |
| 12/24/2008 | CA2691150A1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 12/24/2008 | CA2690762A1 .alpha.-chloro and .alpha.-bromo phosphonate analogs of lysophosphatidic acid and methods of making and using thereof |
| 12/24/2008 | CA2689525A1 Cetp inhibitors derived from benzoxazole arylamides |
| 12/24/2008 | CA2689523A1 Cetp inhibitors derived from benzoxazole arylamides |
| 12/24/2008 | CA2687255A1 Heteroarylamide pyrimidone derivatives |
| 12/24/2008 | CA2687151A1 Heteroarylamide pyrimidone compounds |
| 12/23/2008 | US7468444 Crystalline polymorphic dosage forms of anticholesterol agents; statins; suspending atorvastatin hemi-calcium in water for 16 hours convert the atorvastatin hemi-calcium into Form I |
| 12/23/2008 | US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
| 12/23/2008 | US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion |
| 12/23/2008 | US7468276 Bloodless mammalian placenta for use in generating multipotent stem cells |
| 12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 12/23/2008 | CA2602643C Composition for improving blood cholesterol levels |
| 12/23/2008 | CA2424664C Novel non-imidazole compounds |
| 12/23/2008 | CA2334520C Treatment of immune diseases |
| 12/23/2008 | CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/23/2008 | CA2269334C Therapeutic food composition and method to diminish blood sugar fluctuations |
| 12/23/2008 | CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 12/18/2008 | WO2008154563A1 1, 3 - dihydroxy substituted phenylamide glucokinase activators |
| 12/18/2008 | WO2008153958A2 Crystalline forms of (r)-1-{2-[4'- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto |
| 12/18/2008 | WO2008153632A2 Compositions and methods for treating obesity and related disorders |
| 12/18/2008 | WO2008153502A1 Compositions for prevention and/or treatment of diabetes |
| 12/18/2008 | WO2008153035A1 Liposome preparation for iontophoresis comprising insulin enclosed therein |
| 12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |
| 12/18/2008 | WO2008152226A2 Homogeneous and stable composition rich in oleaginous substances based on a milk product, method for the preparation thereof and uses thereof |
| 12/18/2008 | WO2008152068A2 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 12/18/2008 | WO2008151520A1 A use of sodium selenosulfate for supplementing selenium and enhancing the cure effectiveness of chemotherapy agents,and the rapidly preparing method thereof |
| 12/18/2008 | WO2008151515A1 Fibrate carboxylate compounds, preparation methods and uses thereof |
| 12/18/2008 | WO2008151501A1 A method for preparing a mixture containing natural vitamin p from hippophae rhamnoides l. |
| 12/18/2008 | WO2008151415A1 Combination for treatment of diabetes mellitus |
| 12/18/2008 | WO2008151388A1 Methods of initiating insulin production |
| 12/18/2008 | WO2008115974A3 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors |
| 12/18/2008 | WO2008103574A3 Peroxisome proliferator activated receptor modulators |
| 12/18/2008 | US20080312462 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 12/18/2008 | US20080312417 Ucp5 |
| 12/18/2008 | US20080312333 Agent for Preventing/Ameliorating Life Style-Related Diseases Containing Turmeric Essential Oil Component |
| 12/18/2008 | US20080312299 Imidazole Derivatives as Fructose-1,6-Bisphosphatase Inhibitors and Pharmaceutical Compositions Containing Them |
| 12/18/2008 | US20080312298 Methods for Identification of Modulators of Carm1 Methyl Transferase Activity |
| 12/18/2008 | US20080312282 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme |
| 12/18/2008 | US20080312281 G-Protein Coupled Receptor (Gpr116) Agonists and Use Thereof for Treating Obesity and Diabetes |
| 12/18/2008 | US20080312277 Gpr41 and Modulators Thereof for the Treatment of Insulin-Related Disorders |
| 12/18/2008 | US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity |
| 12/18/2008 | US20080312270 Compounds and methods useful for treating asthma and allergic inflammation |
| 12/18/2008 | US20080312269 Therapeutic Agents |
| 12/18/2008 | US20080312263 Pharmaceutical compositions for the prevention and treatment of atherosclerosis |
| 12/18/2008 | US20080312256 Organic Compounds |
| 12/18/2008 | US20080312244 Squaric Acid Derivatives as Protein Kinase Inhibitors |
| 12/18/2008 | US20080312243 Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions |
| 12/18/2008 | US20080312242 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 12/18/2008 | US20080312231 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases |
| 12/18/2008 | US20080312205 Method and intermediates for the preparation of derivatives of n (1-benzhydrylazetidin-3-yl)-n-phenylmethylsulfonamide |
| 12/18/2008 | US20080312199 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 12/18/2008 | US20080312198 Pharmaceutical products containing hormones and a 25-hydroxy vitamin d compound |
| 12/18/2008 | US20080312188 Glycogen synthase kinase-3 inhibitors |
| 12/18/2008 | US20080312155 modified metastin containing aza-glycine, methyl arginine and N-acetyl tyrosine amino acids; cancer metastasis suppressing activity, a cancer growth suppressing activity |
| 12/18/2008 | US20080312153 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 12/18/2008 | US20080312143 Modified Cdna for High Expression Levels of Factor VIII and Its Derivatives |
| 12/18/2008 | US20080312133 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders |
| 12/18/2008 | US20080312131 Regeneration of Chromatographic Stationary Phases |
| 12/18/2008 | US20080311214 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides |
| 12/18/2008 | US20080311179 for treating disease or condition chosen from Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, sleep, eating disorders |
| 12/18/2008 | US20080311175 Compositions and Methods for Promoting Weight Gain and Feed Conversion |
| 12/18/2008 | US20080311130 Integrin Alpha L I Domain Mutants with Increased Binding Affinity |
| 12/18/2008 | US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof |
| 12/18/2008 | US20080311113 Method for treating adamts-5-associated disease |
| 12/18/2008 | DE60132178T2 CRISTALLINSALZE VON 7-i4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-iMETHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL -(3R,5S)-3,5-DIHYDROXYHEPT-6-ENSÄURE CRISTALLI SALTS OF 7-I4 (4-fluorophenyl) -6-isopropyl-2-iMETHYL (methylsulfonyl) PYRIMIDIN AMINO-5-YL - (3R, 5S) -3,5-dihydroxyhept-6-enoic acid |
| 12/18/2008 | DE102007005045B4 Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Phenothiazine derivatives, processes for their preparation and their use as medicaments |
| 12/18/2008 | CA2692042A1 Compositions and methods for treating obesity and related disorders |
| 12/18/2008 | CA2690455A1 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 12/17/2008 | EP2003207A2 Antisense inhibition of PTP1B expression |
| 12/17/2008 | EP2002863A1 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 12/17/2008 | EP2002842A2 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator |
| 12/17/2008 | EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/17/2008 | EP2002832A2 Composition containing lignan compound |